Movfor 200 Mg Capsules

Product Description

Movfor 200 MG Capsules are used to treat adult individuals with Covid-19 illness who are at a high risk of the disease progressing. They are applied to those who are susceptible to severe sickness and have mild to moderate COVID-19. There may also be other signs, such as sore throat, diarrhoea, or loss of taste or smell. Our provided Movfor 200 MG Capsules are checked under various parameters to ensure their high working and excellent durability. Dry cough, fever, and exhaustion are the most typical signs and symptoms. 

Specification

• Packaging Size  : 40
• Manufacturer  : Cipla Ltd
• Strength  : 200mg
• Composition  : molnupiravir
• Form  : Capsules
• Prescription/Non prescription  : Prescription 

Targeted Antiviral Therapy

Movfor 200 Mg Capsules deliver effective antiviral action for adults diagnosed with mild to moderate COVID-19. With Molnupiravir as the active ingredient, this medication aims to reduce viral replication, helping patients recover sooner and minimizing progression risks.


Emergency Use Authorization

Movfor has received regulatory approval for emergency use, ensuring timely access for those affected by COVID-19. This designation underscores the product's value in addressing urgent public health needs during the pandemic, with safety and efficacy monitored by authorities.


Dosage and Administration

Each dose contains 200 mg of Molnupiravir in capsule form and should be taken orally. The exact dosage and duration of therapy are determined by the treating physician, based on individual patient needs. Always follow physician guidance to achieve optimal outcomes and ensure safety.


Storage & Shelf Life

To maintain effectiveness, Movfor should be stored in a cool, dry place below 30C. Each box contains 40 capsules with a shelf life of 24 months. Proper storage helps preserve the product's quality throughout its intended duration.